On Augugst 22 MSD (known as Merck in the U.S. and Canada) announced the appointment of Pam Cheng to president of MSD China, effective September 1, 2012.
Pam will lead MSD's business in China to ensure that Merck continues to meet customers' needs in China, a critical growth driver for Merck today and in the future. Michel Vounastos, the current president of MSD in China, will be moving to a new senior leadership position at MSD's corporate headquarters in Whitehouse Station, N.J.
Most recently Pam served as chief operating officer of MSD in China, working closely with Michel over the past year. She has been responsible for optimizing operations across the ten regions of China, introducing best practices and driving growth. Based in Shanghai, Pam will report directly to Adam Schechter, executive vice president of Merck and president of Global Human Health Business.
Headquartered in Shanghai, MSD China now has one R&D center and three manufacturing plants, with totally more than 5 000 employees. Today, MSD provides innovative medicines and service to customers and patients across China.